Arkolith/Insider Trading/RLAY/Form 4

Rahmer Peter

See remarksRelay Therapeutics, Inc. (RLAY) · full profile →Form 4 · filed Jan 29, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$100K
Net Open-Market Flow
-$100K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 28, 2026Sell(S)1K$8.45$11K277K
Jan 27, 2026Sell(S)12K$7.62$89K278K
Dec 31, 2025Grant(A)994$2.99$3K338K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-029412) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML